Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Literature DB >> 8704542

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

M F Drummond¹, T O Jefferson.

Abstract

Mesh：

Year: 1996 PMID： 8704542 PMCID： PMC2351717 DOI： 10.1136/bmj.313.7052.275

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

32 in total

1. Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Authors: I S Udvarhelyi; G A Colditz; A Rai; A M Epstein
Journal: Ann Intern Med Date: 1992-02-01 Impact factor: 25.391

2. Economic analysis in randomized control trials.

Authors: M E Adams; N T McCall; D T Gray; M J Orza; T C Chalmers
Journal: Med Care Date: 1992-03 Impact factor: 2.983

3. Cost of neonatal care across a regional health authority.

Authors: R Fordham; D J Field; S Hodges; C Normand; E Mason; P Burton; J Yates; S Male
Journal: J Public Health Med Date: 1992-06

4. Couple screening for cystic fibrosis.

Authors: N J Wald
Journal: Lancet Date: 1991-11-23 Impact factor: 79.321

5. Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors: A Mehrez; A Gafni
Journal: Med Decis Making Date: 1989 Apr-Jun Impact factor: 2.583

6. Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources.

Authors: M Mugford; J Kingston; I Chalmers
Journal: BMJ Date: 1989-10-21

7. The cost-benefit approach.

Authors: A Williams
Journal: Br Med Bull Date: 1974-09 Impact factor: 4.291

8. Benefit and cost analysis in geriatric care. Turning age discrimination into health policy.

Authors: J Avorn
Journal: N Engl J Med Date: 1984-05-17 Impact factor: 91.245

9. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.

Authors: G Oster; A M Epstein
Journal: JAMA Date: 1987-11-06 Impact factor: 56.272

10. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection.

Authors: K A Schulman; L A Lynn; H A Glick; J M Eisenberg
Journal: Ann Intern Med Date: 1991-05-01 Impact factor: 25.391

455 in total

1. Acute urinary retention in men. Management is more complex issue than was described.

Authors: J J Elkabir; A Patel; J A Vale; R O Witherow
Journal: BMJ Date: 1999-10-09

Review 2. Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors: C Bombardier; A Maetzel
Journal: Ann Rheum Dis Date: 1999-11 Impact factor: 19.103

3. The discount rate in the economic evaluation of prevention: a thought experiment.

Authors: L Bonneux; E Birnie
Journal: J Epidemiol Community Health Date: 2001-02 Impact factor: 3.710

4. Handling uncertainty in economic evaluations of healthcare interventions.

Authors: A H Briggs; A M Gray
Journal: BMJ Date: 1999-09-04

5. Cost analysis of nurse telephone consultation in out of hours primary care: evidence from a randomised controlled trial.

Authors: V Lattimer; F Sassi; S George; M Moore; J Turnbull; M Mullee; H Smith
Journal: BMJ Date: 2000-04-15